203 related articles for article (PubMed ID: 19604568)
1. Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
Chua TC; Liauw W; Robertson G; Morris DL
Gynecol Oncol; 2009 Oct; 115(1):166-168. PubMed ID: 19604568
[No Abstract] [Full Text] [Related]
2. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a case report.
Rotruck S; Wilson JT; McGuire J
AANA J; 2014 Apr; 82(2):140-3. PubMed ID: 24902457
[TBL] [Abstract][Full Text] [Related]
3. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
Di Giorgio A; Cardi M; Sammartino P
Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
[No Abstract] [Full Text] [Related]
4. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
5. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) delivered via a modified perfusion system for peritoneal carcinomatosis of colorectal origin.
Cravioto-Villanueva A; Cavazos M; Luna-Perez P; Martinez-Gomez H; Ramirez ML; Solorzano J; Montiel H; Esquivel J
Surg Today; 2016 Aug; 46(8):979-84. PubMed ID: 27138212
[TBL] [Abstract][Full Text] [Related]
7. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma.
Cascales PA; Gil J; Galindo PJ; Machado F; Frutos IM; Paricio PP
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):361-2. PubMed ID: 21676527
[No Abstract] [Full Text] [Related]
9. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for HIPEC in ovarian cancer?
Harter P; du Bois A; Sehouli J; Mahner S; Vergote I; Chiva L; Gonzalez-Martin A; Fotopoulou C
Arch Gynecol Obstet; 2018 Nov; 298(5):859-860. PubMed ID: 30232581
[TBL] [Abstract][Full Text] [Related]
11. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
12. Security and efficiency of a closed-system, turbulent-flow circuit for hyperthermic intraperitoneal chemotherapy after cytoreductive ovarian surgery: perioperative outputs.
Pascual-Ramírez J; Sánchez García S; González Ruiz de la Herrán F; Villarejo Campos P; López de la Manzanara Cano C; Haya Palazuelo J; Padilla Valverde D; Martín Fernández J
Arch Gynecol Obstet; 2014 Jul; 290(1):121-9. PubMed ID: 24488579
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
[TBL] [Abstract][Full Text] [Related]
16. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
[TBL] [Abstract][Full Text] [Related]
17. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
Helm CW
Surg Oncol Clin N Am; 2012 Oct; 21(4):645-63. PubMed ID: 23021722
[TBL] [Abstract][Full Text] [Related]
18. Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.
Chua TC; Liauw W; Robertson G; Chia WK; Soo KC; Alobaid A; Al-Mohaimeed K; Morris DL
Gynecol Oncol; 2009 Jul; 114(1):137-9; author reply 139. PubMed ID: 19368962
[No Abstract] [Full Text] [Related]
19. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases.
Elias D; Goéré D; Dumont F; Honoré C; Dartigues P; Stoclin A; Malka D; Boige V; Ducreux M
Eur J Cancer; 2014 Jan; 50(2):332-40. PubMed ID: 24157254
[TBL] [Abstract][Full Text] [Related]
20. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
Avital I; Brücher BL; Nissan A; Stojadinovic A
Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
